RecruitingNot ApplicableNCT04556890

Pain and Major Depressive Disorder

Multi-target Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Major Depressive Disorder (MDD) and Comorbid Pain


Sponsor

University of California, Los Angeles

Enrollment

54 participants

Start Date

Mar 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study will examine the effects of brain stimulation on pain symptoms associated with Major depressive disorder. This study will enroll 54 Subjects. Study subjects will be asked to complete surveys about their mood and well-being, 2 blood draws, 2 MRIs, 3 electroencephalograms, and receive 30 treatments of blinded transcranial magnetic stimulation. There is no control group as all subjects will receive some form of active treatment. Subjects are required to participate in 30-33 study visits and volunteer 40 hours of their time. Compensation for this study is $150 for completing all study activities.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether transcranial magnetic stimulation (TMS) — a non-invasive brain stimulation technique — can help people who suffer from both treatment-resistant depression and chronic pain conditions like fibromyalgia or chronic fatigue syndrome. **You may be eligible if...** - You are between 18 and 75 years old and right-handed - You speak English fluently - You have been diagnosed with moderate-to-severe major depressive disorder that has not responded to at least 2 different antidepressant medications and psychotherapy - You have been diagnosed with fibromyalgia or chronic fatigue syndrome with pain lasting at least 3 months **You may NOT be eligible if...** - You are pregnant - You have an active plan or intent to harm yourself - You have previously had TMS treatment - You have a metal implant in or near your head (such as a cochlear implant or pacemaker near the scalp) - You have a skin infection or poor skin condition on your scalp Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEActive rTMS/Active iTBS DFPLC/Sham Pain M1

Active rTMS treatment for depression (600 pulses of active intermittent theta burst (iTBS) administrated at 120% MT to the left DLPFC) and sham treatment for pain at M1

DEVICEActive rTMS/Active iTBS

Active rTMS treatment for both, depression and pain (600 pulses of iTBS to left DLPFC followed by 600 iTBS + 1500 pulses of 10 Hz to M1


Locations(1)

UCLA Semel Institute

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04556890


Related Trials